Cargando…
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
Pulmonary bacterial infections present a significant health risk to those with chronic respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary disease (COPD). With the emergence of antimicrobial resistance (AMR), novel therapeutics are desperately needed to comba...
Autores principales: | Flint, Rohan, Laucirica, Daniel R., Chan, Hak-Kim, Chang, Barbara J., Stick, Stephen M., Kicic, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453214/ https://www.ncbi.nlm.nih.gov/pubmed/37626867 http://dx.doi.org/10.3390/cells12162057 |
Ejemplares similares
-
Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
por: Laucirica, Daniel R., et al.
Publicado: (2022) -
Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation
por: Vaitekenas, Andrew, et al.
Publicado: (2021) -
Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?
por: Ling, Kak-Ming, et al.
Publicado: (2023) -
Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis
por: Ng, Renee N., et al.
Publicado: (2021) -
Complete Genomes of Three Pseudomonas aeruginosa Bacteriophages, Kara-mokiny 1, Kara-mokiny 2, and Kara-mokiny 3
por: Ng, Renee N., et al.
Publicado: (2022)